An analysis of short‐term cultured patient‐derived CRC cells with wild‐type p53 (HROC24, HROC113, HHC6548) confirmed that a combined treatment with irinotecan plus entinostat was superior over the single drugs (Fig. S1C). Here, TP53 is linked to colorectal carcinoma.